BLTE
Price
$137.23
Change
+$2.30 (+1.70%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
5.89B
70 days until earnings call
Intraday BUY SELL Signals
PRAX
Price
$278.60
Change
+$20.52 (+7.95%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
9.34B
68 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BLTE vs PRAX

Header iconBLTE vs PRAX Comparison
Open Charts BLTE vs PRAXBanner chart's image
BLTE vs PRAX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BLTE vs. PRAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLTE is a StrongBuy and PRAX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2026
Stock price -- (BLTE: $134.93 vs. PRAX: $258.08)
Brand notoriety: BLTE and PRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLTE: 232% vs. PRAX: 375%
Market capitalization -- BLTE: $5.89B vs. PRAX: $9.34B
BLTE [@Biotechnology] is valued at $5.89B. PRAX’s [@Biotechnology] market capitalization is $9.34B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLTE’s FA Score shows that 0 FA rating(s) are green whilePRAX’s FA Score has 0 green FA rating(s).

  • BLTE’s FA Score: 0 green, 5 red.
  • PRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, BLTE is a better buy in the long-term than PRAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLTE’s TA Score shows that 5 TA indicator(s) are bullish while PRAX’s TA Score has 4 bullish TA indicator(s).

  • BLTE’s TA Score: 5 bullish, 3 bearish.
  • PRAX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BLTE is a better buy in the short-term than PRAX.

Price Growth

BLTE (@Biotechnology) experienced а -4.99% price change this week, while PRAX (@Biotechnology) price change was -26.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.54%. For the same industry, the average monthly price growth was -1.96%, and the average quarterly price growth was +3.26%.

Reported Earning Dates

BLTE is expected to report earnings on Aug 12, 2026.

PRAX is expected to report earnings on Aug 10, 2026.

Industries' Descriptions

@Biotechnology (-1.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRAX($9.34B) has a higher market cap than BLTE($5.89B). PRAX YTD gains are higher at: -12.438 vs. BLTE (-15.648). BLTE has higher annual earnings (EBITDA): -63.25M vs. PRAX (-357.2M). PRAX has more cash in the bank: 787M vs. BLTE (276M). BLTE has less debt than PRAX: BLTE (510K) vs PRAX (1.44M). BLTE (0) and PRAX (0) have equivalent revenues.
BLTEPRAXBLTE / PRAX
Capitalization5.89B9.34B63%
EBITDA-63.25M-357.2M18%
Gain YTD-15.648-12.438126%
P/E RatioN/AN/A-
Revenue00-
Total Cash276M787M35%
Total Debt510K1.44M36%
TECHNICAL ANALYSIS
Technical Analysis
BLTEPRAX
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 16 days ago
80%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BLTE
Daily Signal:
Gain/Loss:
PRAX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBFS16.790.43
+2.63%
Pioneer Bancorp
EZPW31.110.15
+0.48%
EZCORP
CAPN11.03N/A
N/A
Cayson Acquisition Corp
FERAU10.54N/A
N/A
Fifth Era Acquisition Corp I
UHAL56.25-0.41
-0.72%
U-Haul Holding Company

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
-8.21%
RAIN - BLTE
48%
Loosely correlated
-2.59%
DNTH - BLTE
25%
Poorly correlated
-8.87%
ROIV - BLTE
25%
Poorly correlated
-2.82%
PRAX - BLTE
24%
Poorly correlated
-23.00%
ACOG - BLTE
24%
Poorly correlated
-2.52%
More